Other presentations focused on new therapies for diabetic kidney disease, a review of up and coming treatment trials, and an interactive session focused on strategies for treating patients who have failed standard therapies. A special session was also held to highlight research projects being conducted by UNC faculty members and trainees.
The 34th Annual Meeting will be held in Spring, 2020. Details will be posted on the annual meeting page as they become available.
The GDCN was established in 1985 as a means of enhancing communication and research efforts between community nephrology offices, academic nephrology and pathology departments, and the University of North Carolina at Chapel Hill School of Medicine. Its purpose is to learn more about the causes and pathogenesis of glomerular diseases, as well as to find the most effective treatments for patients with these diseases. Every year, network members meet for continuing education and to review new and ongoing studies involving patients with glomerular disease.